Cause-specific mortality among Queensland people with cirrhosis, by cirrhosis aetiology and decompensation status, 2007-22: a retrospective cohort study

Vikas Bhasker; Jessica R Fong; Paul J Clark; Gunter F Hartel; Richard Skoien; James O'Beirne; Elizabeth E Powell; Patricia C Valery

doi:10.5694/mja2.70036

Back

Cause-specific mortality among Queensland people with cirrhosis, by cirrhosis aetiology and decompensation status, 2007-22: a retrospective cohort study

Journal article

Open access

Peer reviewed

Cause-specific mortality among Queensland people with cirrhosis, by cirrhosis aetiology and decompensation status, 2007-22: a retrospective cohort study

Vikas Bhasker, Jessica R Fong, Paul J Clark, Gunter F Hartel, Richard Skoien, James O'Beirne, Elizabeth E Powell and Patricia C Valery

Medical Journal of Australia, Vol.223(9), pp.473-483

2025

DOI: https://doi.org/10.5694/mja2.70036

PMID: 40931480

Files and links (2)

pdf

Medical Journal of Australia - 2025 - Bhasker - Cause‐specific mortality among Queensland people with cirrhosis by1.31 MBDownload View

Published Version (Advanced Access)CC BY-NC-ND V4.0, Open Access

url

http://dx.doi.org/10.5694/mja2.70036View

Published VersionCC BY-NC-ND V4.0

Abstract

Liver diseases

Cancer

cirrhosis

mortality

cirrhosis aetiology

alcohol

MASLD

Objective: To determine the cumulative incidence of overall and cause-specific mortality among Queensland residents admitted to hospital with cirrhosis during 2007-22, by cirrhosis aetiology. Study design: Retrospective cohort study; analysis of linked Queensland Hospital Admitted Patient Data Collection and Queensland Registry of Births, Deaths and Marriages data. Settings, participants: Adult Queensland residents (18 years or older) admitted to Queensland hospitals with cirrhosis during 1 July 2007 - 31 December 2022. Main outcome measures: Ten-year mortality, all-cause and cause-specific (liver-related, extrahepatic cancer, cardiovascular disease), by cirrhosis aetiology. Results: A total of 22 525 people were followed for a median of 6.9 years (interquartile range, 3.5-11.1 years). Their mean age at the index admission with cirrhosis was 61.2 years (standard deviation, 13.0 years), 14 895 were men (66.1%), and the most frequent causes of cirrhosis were alcohol use (9550 people, 42.4%), metabolic dysfunction-associated steatotic liver disease (MASLD; 5108 people, 22.7%), and chronic hepatitis C virus (HCV) infection (4780 people, 21.2%). A total of 12 387 people (55.0%) had died by 31 December 2022; overall mortality among people with alcohol-related cirrhosis was 57.9%, with MASLD cirrhosis 52.1%, and with HCV-related cirrhosis 51.6%. The proportions of deaths attributed to liver disease were larger for people who experienced decompensation during follow-up than those who did not (alcohol-related cirrhosis: 2538 of 3890 deaths [65.2%] v 523 of 1637 [31.9%]; HCV-related cirrhosis: 1158 of 1714 deaths [67.6%] v 331 of 753 [44.0%]). Ten-year liver-related mortality was highest among people with alcohol-related cirrhosis (48.8%; 95% confidence interval [CI], 47.2-50.4%) or HCV-related cirrhosis (44.3%; 95% CI, 42.3-46.3%); ten-year extrahepatic cancer mortality (18.8%; 95% CI, 16.8-20.9%) and cardiovascular disease mortality (15.6%; 95% CI, 13.8-17.7%) were highest among people with MASLD cirrhosis. In multivariable competing risks regression analyses, people with MASLD cirrhosis were less likely than people with alcohol-related cirrhosis to die of liver disease (adjusted subdistribution hazard ratio [sHR], 0.55; 95% CI, 0.51-0.60) and more likely to die of extrahepatic cancer (adjusted sHR, 1.21; 95% CI, 1.04-1.41). Conclusion: Mortality among people who have been hospitalised with cirrhosis is high, and there is substantial variation in cause-specific mortality by cirrhosis aetiology. Care for these patients could be improved by identifying chronic liver disease earlier, and by treating cardiovascular disease and extrahepatic malignancies in people with MASLD.

Details

Title: Cause-specific mortality among Queensland people with cirrhosis, by cirrhosis aetiology and decompensation status, 2007-22: a retrospective cohort study
Authors: Vikas Bhasker - QIMR Berghofer Medical Research Institute
Jessica R Fong - The University of Queensland
Paul J Clark (Author) - Princess Alexandra Hospital
Gunter F Hartel - QIMR Berghofer Medical Research Institute
Richard Skoien - Royal Brisbane and Women's Hospital
James O'Beirne - Sunshine Coast University Hospital
Elizabeth E Powell (Author) - Princess Alexandra Hospital
Patricia C Valery (Corresponding Author) - QIMR Berghofer Medical Research Institute
Publication details: Medical Journal of Australia, Vol.223(9), pp.473-483
Publisher: John Wiley & Sons, Inc.
Date published: 2025
DOI: 10.5694/mja2.70036
ISSN: 1326-5377; 0025-729X
PMID: 40931480
Copyright note: © 2025 The Author(s). Medical Journal of Australia published by John Wiley & Sons Australia, Ltd on behalf of AMPCo Pty Ltd. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium,provided the original work is properly cited, the use is non-commercial and no modificationsor adaptations are made.
Data Availability: The data cannot be shared because of privacy and ethics restrictions.
Organisation Unit: School of Health and Behavioural Sciences - Legacy
Language: English
Record Identifier: 991169145602621
Output Type: Journal article

Metrics

3 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration
Web Of Science research areas: Gastroenterology & Hepatology